Carregant...
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterized by a Th2 response, serum eosinophilia, and increased total serum IgE to Aspergillus fumigatus. ABPA occurs in cystic fibrosis (CF) and asthma. Omalizumab is a humanized recombinant monoclonal antibody against IgE...
Guardat en:
| Publicat a: | J Asthma Allergy |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6016275/ https://ncbi.nlm.nih.gov/pubmed/29950869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S156049 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|